Mycell Technologies LLC (Paramus, N.J.), an intellectual property and investment holding company specializing in the development of proprietary liquid formulations of concentrated omega-3 ingredients, has closed an institutional non-controlling minority investment of $10 million. Terms and the identity of the strategic institutional investor were not disclosed. "We are now positioned for extraordinary growth at Mycell Technologies and Oceans Omega, our flagship ingredient subsidiary," said Benjamin D. Mamola, chairman and CEO. Oceans Omega LLC is a supplier of stabilized omega-3 EPA/DHA ingredients to the food and beverage markets.
Disclaimer: NCN does not warrant the accuracy, reliability, or timeliness of any NCN news item. Before relying on any NCN News item the information should be independently verified.
For more finance and investment information, visit Nutrition Capital Network news.